HK1250491A1 - 穩定化的醫藥組合物 - Google Patents

穩定化的醫藥組合物

Info

Publication number
HK1250491A1
HK1250491A1 HK18109928.8A HK18109928A HK1250491A1 HK 1250491 A1 HK1250491 A1 HK 1250491A1 HK 18109928 A HK18109928 A HK 18109928A HK 1250491 A1 HK1250491 A1 HK 1250491A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
stabilized pharmaceutical
stabilized
composition
pharmaceutical
Prior art date
Application number
HK18109928.8A
Other languages
English (en)
Inventor
田崎弘朗
吉田允
綱島大介
東亮太
Original Assignee
安斯泰來製藥有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 安斯泰來製藥有限公司 filed Critical 安斯泰來製藥有限公司
Publication of HK1250491A1 publication Critical patent/HK1250491A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK18109928.8A 2015-04-27 2018-08-01 穩定化的醫藥組合物 HK1250491A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015090702 2015-04-27
JP2015252958 2015-12-25
PCT/JP2016/063004 WO2016175192A1 (ja) 2015-04-27 2016-04-26 安定化されてなる医薬組成物

Publications (1)

Publication Number Publication Date
HK1250491A1 true HK1250491A1 (zh) 2018-12-21

Family

ID=57198490

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18109928.8A HK1250491A1 (zh) 2015-04-27 2018-08-01 穩定化的醫藥組合物

Country Status (12)

Country Link
US (1) US10188737B2 (zh)
EP (1) EP3290036A4 (zh)
JP (2) JP6112530B2 (zh)
KR (1) KR20170139154A (zh)
CN (1) CN108135898A (zh)
CA (1) CA2983400A1 (zh)
HK (1) HK1250491A1 (zh)
MX (1) MX2017013788A (zh)
PH (1) PH12017501832A1 (zh)
RU (1) RU2017140923A (zh)
TW (1) TWI689306B (zh)
WO (1) WO2016175192A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018079570A1 (ja) * 2016-10-26 2018-05-03 アステラス製薬株式会社 安定な医薬組成物
KR102406067B1 (ko) 2017-10-25 2022-06-08 현대자동차주식회사 가변형 에어벤트
KR20240128987A (ko) 2021-12-30 2024-08-27 바이오메아 퓨전, 인크. Flt3의 억제제로서의 피라진 화합물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006045218A (ja) 2004-07-08 2006-02-16 Ono Pharmaceut Co Ltd 経口投与用医薬組成物
PT2805940T (pt) 2012-01-17 2017-02-03 Astellas Pharma Inc Composto de pirazino-carboxamida
JP6084371B2 (ja) 2012-05-23 2017-02-22 富士製薬工業株式会社 薬剤安定化医薬組成物
WO2015182628A1 (ja) * 2014-05-28 2015-12-03 アステラス製薬株式会社 ピラジンカルボキサミド化合物を有効成分とする医薬組成物

Also Published As

Publication number Publication date
US10188737B2 (en) 2019-01-29
WO2016175192A1 (ja) 2016-11-03
PH12017501832A1 (en) 2018-04-23
CA2983400A1 (en) 2016-11-03
TW201703772A (zh) 2017-02-01
JP6112530B2 (ja) 2017-04-12
TWI689306B (zh) 2020-04-01
MX2017013788A (es) 2018-03-27
RU2017140923A (ru) 2019-05-27
EP3290036A1 (en) 2018-03-07
JPWO2016175192A1 (ja) 2017-05-18
KR20170139154A (ko) 2017-12-18
CN108135898A (zh) 2018-06-08
US20180133325A1 (en) 2018-05-17
EP3290036A4 (en) 2019-01-02
JP2017119703A (ja) 2017-07-06

Similar Documents

Publication Publication Date Title
IL265360B (en) Pharmaceutical composition
IL265260B (en) pharmaceutical preparations
GB201506658D0 (en) Pharmaceutical compounds
GB201504675D0 (en) Pharmaceutical compounds
GB201506660D0 (en) Pharmaceutical compounds
IL262654A (en) Pharmacy preparation
GB201517216D0 (en) Pharmaceutical compounds
IL265349A (en) Pharmaceutical composition
SI3278801T1 (sl) Farmacevtski sestavek, ki vsebuje mirabegron
GB201506933D0 (en) Pharmaceutical compounds
GB201502567D0 (en) Pharmaceutical compounds
GB201506526D0 (en) Medicinal composition
IL263040A (en) Pharmaceutical composition comprising eteplirsen
GB201521462D0 (en) Pharmaceutical composition
GB201615917D0 (en) Pharmaceutical composition
HK1250491A1 (zh) 穩定化的醫藥組合物
GB201515310D0 (en) Pharmaceutical composition
HK1245073A1 (zh) 藥物組合物
PL3454838T3 (pl) Kompozycja farmaceutyczna
GB201520862D0 (en) Pharmaceutical composition
GB201615910D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
IL265436B (en) Pharmacy preparation
PL3424500T3 (pl) Kompozycja farmaceutyczna zawierająca famitynib
GB201620519D0 (en) Pharmaceutical composition